Evidence map›Paper›PMID 38189974›Full record

ArticleGraefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie2024

Genetic profile of syndromic retinitis pigmentosa in Portugal.

Telmo Cortinhal, Cristina Santos, Sara Vaz-Pereira, Ana Marta, Lilianne Duarte, Vitor Miranda, José Costa, Ana Berta Sousa, Virginie G Peter, Karolina Kaminska and 8 more

Open access · hybridAbstract readMulticenter Study
In one paragraph

Article in Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
2.1field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 9 institutions in 3 countries.

Telmo CortinhalDepartment of Ophthalmology, Centro Hospitalar e Universitário de Coimbra (CHUC), Coimbra, Portugal.ORCID http://orcid.org/0000-0002-9016-9031
Cristina SantosInstituto de Oftalmologia Dr. Gama Pinto (IOGP), Lisboa, Portugal.ORCID http://orcid.org/0000-0002-4751-2180
Sara Vaz-PereiraDepartment of Ophthalmology, Centro Hospitalar Universitário de Lisboa Norte (CHULN), Lisboa, Portugal.ORCID http://orcid.org/0000-0001-6125-5486
Ana MartaDepartment of Ophthalmology, Centro Hospitalar e Universitário de Santo António (CHUdSA), Porto, Portugal.ORCID http://orcid.org/0000-0003-3495-4649
Lilianne DuarteDepartment of Ophthalmology, Centro Hospitalar de Entre Douro e Vouga (CHEDV), Santa Maria da Feira, Portugal.ORCID http://orcid.org/0000-0003-3953-0730
Vitor MirandaDepartment of Ophthalmology, Centro Hospitalar de Entre Douro e Vouga (CHEDV), Santa Maria da Feira, Portugal.ORCID http://orcid.org/0000-0003-4480-5225
José CostaDepartment of Ophthalmology, Hospital de Braga (HB), Braga, Portugal.ORCID http://orcid.org/0000-0002-6026-1929
Ana Berta SousaMedical Genetics Unit, Hospital Pediátrico, Centro Hospitalar e Universitário de Lisboa Norte (CHULN), Lisboa, Portugal.ORCID http://orcid.org/0000-0001-5889-2492
Virginie G PeterInstitute of Molecular and Clinical Ophthalmology Basel (IOB), 4031, Basel, Switzerland.ORCID http://orcid.org/0000-0001-8157-9568
Karolina KaminskaInstitute of Molecular and Clinical Ophthalmology Basel (IOB), 4031, Basel, Switzerland.ORCID http://orcid.org/0000-0002-4720-5527
Carlo RivoltaInstitute of Molecular and Clinical Ophthalmology Basel (IOB), 4031, Basel, Switzerland.ORCID http://orcid.org/0000-0002-0733-9950
Ana Luísa CarvalhoMedical Genetics Unit, Centro Hospitalar e Universitário de Coimbra (CHUC), Coimbra, Portugal.
Jorge SaraivaMedical Genetics Unit, Centro Hospitalar e Universitário de Coimbra (CHUC), Coimbra, Portugal.
Célia Azevedo SoaresMedical Genetics Department, Centro de Genética Médica Jacinto Magalhães, Centro Hospitalar e Universitário do Porto (CHUP), Porto, Portugal.ORCID http://orcid.org/0000-0002-2907-0091
Rufino SilvaDepartment of Ophthalmology, Centro Hospitalar e Universitário de Coimbra (CHUC), Coimbra, Portugal.
Joaquim MurtaDepartment of Ophthalmology, Centro Hospitalar e Universitário de Coimbra (CHUC), Coimbra, Portugal.
Luísa Coutinho SantosInstituto de Oftalmologia Dr. Gama Pinto (IOGP), Lisboa, Portugal.ORCID http://orcid.org/0000-0002-6181-4505
João Pedro MarquesDepartment of Ophthalmology, Centro Hospitalar e Universitário de Coimbra (CHUC), Coimbra, Portugal. marquesjoaopedro@gmail.com.ORCID http://orcid.org/0000-0002-1014-0483
Hospitais da Universidade de Coimbra · PTUnidade Local de Saúde de Entre Douro e Vouga · PTUniversidade do Porto · PTUniversity of Basel · CHCentro Hospitalar Lisboa Norte · PTHospital Braga · PTUniversidade Nova de Lisboa · PTUniversity of Leicester · GBUniversity of Lisbon · PT

Funding

Solve-Ret EJPRD19-234
6 · The paper itself

Abstract

purposeRetinitis pigmentosa (RP) comprises a genetically and clinically heterogeneous group of inherited retinal degenerations, where 20-30% of patients exhibit extra-ocular manifestations (syndromic RP). Understanding the genetic profile of RP has important implications for disease prognosis and genetic counseling. This study aimed to characterize the genetic profile of syndromic RP in Portugal.

methodsMulticenter, retrospective cohort study. Six Portuguese healthcare providers identified patients with a clinical diagnosis of syndromic RP and available genetic testing results. All patients had been previously subjected to a detailed ophthalmologic examination and clinically oriented genetic testing. Genetic variants were classified according to the American College of Medical Genetics and Genomics; only likely pathogenic or pathogenic variants were considered relevant for disease etiology.

resultsOne hundred and twenty-two patients (53.3% males) from 100 families were included. Usher syndrome was the most frequent diagnosis (62.0%), followed by Bardet-Biedl (19.0%) and Senior-Løken syndromes (7.0%). Deleterious variants were identified in 86/100 families for a diagnostic yield of 86.0% (87.1% for Usher and 94.7% for Bardet-Biedl). A total of 81 genetic variants were identified in 25 different genes, 22 of which are novel. USH2A and MYO7A were responsible for most type II and type I Usher syndrome cases, respectively. BBS1 variants were the cause of Bardet-Biedl syndrome in 52.6% of families. Best-corrected visual acuity (BCVA) records were available at baseline and last visit for 99 patients (198 eyes), with a median follow-up of 62.0 months. The mean BCVA was 56.5 ETDRS letters at baseline (Snellen equivalent ~ 20/80), declining to 44.9 ETDRS letters (Snellen equivalent ~ 20/125) at the last available follow-up (p < 0.001).

conclusionThis is the first multicenter study depicting the genetic profile of syndromic RP in Portugal, thus contributing toward a better understanding of this heterogeneous disease group. Usher and Bardet-Biedl syndromes were found to be the most common types of syndromic RP in this large Portuguese cohort. A high diagnostic yield was obtained, highlighting current genetic testing capabilities in providing a molecular diagnosis to most affected individuals. This has major implications in determining disease-related prognosis and providing targeted genetic counseling for syndromic RP patients in Portugal.

Indexed as

Genetic TestingMutationRetinitis PigmentosaAdolescentAdultAgedChildChild, PreschoolDNADNA Mutational AnalysisEye ProteinsFemaleFollow-Up StudiesHumansMaleMiddle AgedDNAEye ProteinsGenotypeInherited retinal diseasesOphthalmic geneticsSyndromic retinitis pigmentosa

Identifiers

PMID38189974
PMCPMC11106148
OpenAlexW4390663813

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.